US FDA approves Pfizer's nasal spray for migraine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
FDA approves Pfizer's (PFE) migraine nasal spray
March 10, 2023 11:44 AM ESTPfizer (NYSE: PFE) shares edged higher despite the overall dip in equities in the early part of Friday's session after it announced the U.S. Food and Drug Administration (FDA) has approved its migraine nasal spray.
ZAVZPRET was shown to be "statistically... More
